Latest news with #ResearchTrianglePark
Reuters
21 hours ago
- Business
- Reuters
Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm
July 21 (Reuters) - Biogen (BIIB.O), opens new tab will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S. amid President Donald Trump's tariff threats. Biogen joins major drugmakers such as Eli Lilly(LLY.N), opens new tab, Roche (ROG.S), opens new tab and Merck, who have all announced investments in the U.S. as the industry braces for potential import levies. Drugs have so far been exempt from Trump's reciprocal tariffs, but he has often argued that separate levies are needed to bolster domestic manufacturing and avoid relying on other countries for medicine supply. Earlier this month, Trump said the tariffs may be delayed, but could be as high as 200%. On Monday, Biogen said it will invest in North Carolina's Research Triangle Park (RTP), the home of its largest manufacturing plants that produce key therapies for multiple sclerosis and Alzheimer's. The investments will expand Biogen's ability to develop and produce certain gene-targeting therapies, and add fill‑finish facilities, automation and artificial intelligence, the company said. The drugmaker has invested about $10 billion in its North Carolina manufacturing to date. It has seven factories in the state with an eighth expected to start working in the second half of 2025.
Yahoo
a day ago
- Business
- Yahoo
Biogen to invest $2 billion more in North Carolina
(Reuters) -Drugmaker Biogen (BIIB) said on Monday it will invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park. The company has invested about $10 billion in its North Carolina manufacturing to date. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
a day ago
- Business
- Reuters
Drugmaker Biogen to invest $2 billion more in North Carolina
July 21 (Reuters) - Biogen (BIIB.O), opens new tab will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as it seeks to expand its presence in the U.S. amid President Donald Trump's tariff threats. The company said the investment will go to its manufacturing plants in North Carolina's Research Triangle Park (RTP), which produce its major therapies for multiple sclerosis and Alzheimer's. Biogen has invested about $10 billion in its North Carolina manufacturing to date. The drugmaker said it plans to continue investing in multiple modalities and factories across its two campuses in RTP.
Reuters
a day ago
- Business
- Reuters
Biogen to invest $2 billion more in North Carolina
July 21 (Reuters) - Drugmaker Biogen (BIIB.O), opens new tab said on Monday it will invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park. The company has invested about $10 billion in its North Carolina manufacturing to date.
Yahoo
a day ago
- Business
- Yahoo
Biogen to invest $2 billion more in North Carolina
(Reuters) -Drugmaker Biogen said on Monday it will invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park. The company has invested about $10 billion in its North Carolina manufacturing to date. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
